Log In
Print
BCIQ
Print
Print this Print this
 

Posidur, bupivacaine (formerly Optesia)

  Manage Alerts
Collapse Summary General Information
Company Durect Corp.
DescriptionInjectable biodegradable gel for sustained-release delivery of bupivacaine
Molecular Target Sodium channel
Mechanism of ActionNa channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationPain
Indication DetailsTreat postoperative pain; Treat postoperative pain following inguinal hernia; Treat postoperative pain following shoulder surgery
Regulatory Designation

U.S. - Undisclosed Review (Treat postoperative pain)

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$212.5M

$27.5M

$185.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today